Elanco Animal Health Inc
(NYSE:ELAN)
$
14.12
-0.15 (-1.05%)
Market Cap: 6.98 Bil
Enterprise Value: 10.92 Bil
PE Ratio: 35.30
PB Ratio: 1.07
GF Score: 71/100 Elanco Animal Health Inc at Bank of America Merrill Lynch Healthcare Conference (Virtual) Transcript
May 14, 2020 / 05:00PM GMT
Release Date Price:
$19.38
(+0.47%)
Michael Leonidovich Ryskin
BofA Merrill Lynch, Research Division - Associate
Hi, good afternoon. Thank you for joining us. My name is Mike Ryskin. I'm on the Research Team on the Life Science Tools team, but also focusing on Animal Health. So for our next session, we have Elanco. And I'm honored to be joined by Jeff Simmons, CEO. We've also got the IR team on the line, and Todd Young, CFO, may be hopping in any second now. Jeff, thank you for joining us.
Jeffrey N. Simmons
Elanco Animal Health Incorporated - President, CEO & Director
Thanks, Mike. Great to be here.
Questions & Answers
Michael Leonidovich Ryskin
BofA Merrill Lynch, Research Division - Associate
Great. So just to get the ball rolling, we got a full slate of questions, but maybe just to start, can you sort of give us an overview of the distributor issues that came up in this last earnings call, I think, has been the biggest focus for investors?
Could you walk through the status of your distributor relationships? How that's
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot